Ms. Emiko Higashi has an extensive career in finance focusing on M&A, and founded her own consulting firm in Silicon Valley advising on technology related matters. Ms. Higashi also serves as an outside board member of several companies including Takeda Pharmaceutical Company Limited.
She discussed about the current state of Silicon Valley Ecosystem, and Social Entrepreneurship.
Emiko Higashi Brief Profile
Board of Directors, Rambus Inc. (NYSE) from July 2017 to present
Board of Directors, Takeda Pharmaceutical (TSE) from June 2016 to present
Board of Directors, MetLife Insurance K.K. (subsidiary of MetLife) from June 2016 to present
Board of Directors, KLA -Tencor (NASDAQ) from Nov. 2010 to present
Advisory board, Datavant from July 2017 to present
Harvard Business School Global Advisory Board from April 2016 to present
Board of Directors, Invensense (NASDAQ) from Oct. 2014 to May 2017
Board of Directors, Zeptor (private) from 2010 to 2017
Board of directors, Stentor Software (private) from 2000 to 2006
Board of Directors, Zen Research (LSE) from 2001 to 2002
Founder/Managing Director, Tomon Partners (renamed Tohmon Capital Partners) in San Francisco and Tokyo from 2003 to present
Co-founder/CEO, Gilo Ventures in Silicon Valley and Tel Aviv from 2001 to 2003
Managing Director, co-head of global technology M&A practice at Merrill Lynch & Co. from 1994 to 2000
Director, M&A at Wasserstein Perella & Co. in New York from 1988 to1994
Associate, Corporate Finance at Lehman Brothers in New York from 1985 to 1988
Analyst, McKinsey &Co. in Tokyo from 1982 to 1983
Specialties: Mergers and acquisitions, strategic advisory, strategic planning, and capital raising. Public company board service in the U.S. and Japan.